About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
Trade
Access to Medicines
Should we respect patents or people?
Access to Medicines
The President’s Trumpeteering on Drug Prices is Really a Toy Whistle
Access to Medicines
Drug Companies Getting Away with Murder – Trump’s Solution: Round Up Foreign Country Targets
Access to Medicines
Lies, Distortions, and False Promises: The U.S. Position on Compulsory Licenses in the 2018 Special 301 Report
Access to Medicines
Don’t Be Afraid of Compulsory Licenses Despite US Threats: Special 301 Reports 1998-2017 – Listing Concern...
Access to Medicines
Canada Blinks in Face of US/Pharma Pressure – Supreme Court Adopts Wink-Wink Patent Utility Rule
Access to Medicines
Trump’s Draft Executive Order on Pharmaceutical Pricing: Dangerous Medicine for Consumers at Home and Abroad
Access to Medicines
Trump’s Drug Pricing Executive Order is Likely to be an Unfettered Giveaway to Big Pharma: Insights from 201...
Access to Medicines
TPP = Transnational Pharmaceutical Profiteering
Access to Medicines
LDCs be damned: USTR and Big Pharma seeks to eviscerate Least Developed Countries’ insulation from pharm...
Access to Medicines
Obama’s USTR Wins Big for Big Pharma in the Trans Pacific Partnership Deal
Access to Medicines
US Position on LDC Pharmaceutical Extension of TRIPS Transition Period
Access to Medicines
Will U.S. create barriers to LDCs’ future access to medicines?
Access to Medicines
Trans-Pacific Partnership Transparency for the Big Pharma Wrecking Crew
Access to Medicines
Urgent Action NOW: defend AIDS drugs from Fast Track Attack
SEE MORE
